Abstract: A vehicle object detection system configured to generate a judgement on whether a target object which has been detected to enter the detection area is an alert object, and to output the judgement to a warning which is configured to warn a driver of the subject vehicle that a target object is present in the detection area behind the subject vehicle based on the judgement indicating that the target object is an alert object, wherein the system is configured to delay generating the judgement until a specified period of time has elapsed from a point in time when the target object entered the detection area from an adjacent area located lateral to the detection area and/or is configured to generate the judgement based on a change in distance between the target object and the subject vehicle during said specified period of time.

Abstract: A resin composition containing: a block copolymer (I) having a polymer block (a1) containing a structural unit derived from an aromatic vinyl compound and a polymer block (a2) containing a structural unit derived from a conjugated diene compound; a plasticizer (II); and a biomass-derived polyolefin-based resin (III); in which the plasticizer (II) contains a plasticizer (II-1) containing a biomass-derived raw material; and in which the resin composition has a biobased content of 45% by mass or more, and a molded body obtained by using the resin composition.

Abstract: A cerium oxide nanoparticle whose surface is covered with a vinyl polymer has a heterocyclic amine skeleton such as piperazine, pyridine, imidazole, or carbazole or with a polyamide having a heterocyclic amine skeleton such as piperazine, pyridine, imidazole, or carbazole; and a decomposition method of a nucleic acid or a polypeptide by using the cerium oxide nanoparticle.

Abstract: A polypropylene-based resin composition, a hydrogenated block copolymer contained in the polypropylene-based resin composition, a molded article containing the polypropylene-based resin composition, and an interior-exterior decorative material for automobiles, which includes the molded article. The polypropylene-based resin composition contains a polypropylene-based polymer (A), an ethylene-?-olefin copolymer rubber (B), and a hydrogenated block copolymer (C). In the polypropylene-based resin composition, the hydrogenated block copolymer (C) is a hydrogenated product of a block copolymer having at least one polymer block (C-1) mainly composed of an aromatic vinyl compound unit, and having at least one polymer block (C-2) mainly composed of a butadiene (Bd) unit and an isoprene (Ip) unit, a content of the aromatic vinyl compound units in the hydrogenated block copolymer is less than 30% by mass, and a vinyl bond amount of the polymer block (C-2) is 20% or less.

Abstract: An object of the present invention is to provide a lipid composition capable of achieving excellent nucleic acid delivery for a wide variety of nucleic acids. According to the present invention, there is provided a lipid composition containing a first lipid which is a lipid represented by Formula (1) or a salt thereof, sterols, and nucleic acid, in which a ratio of the number of moles of the first lipid in the lipid composition to the number of moles of sterols in the lipid composition is 0.300 or more and less than 1.299.

Abstract: An object of the present invention is to provide a tumor therapeutic agent and a kit which have superior antitumor effects as compared with gemcitabine, a taxane antitumor agent, and a combination therapy thereof which have been put on the market. According to the present invention, there is provided a tumor therapeutic agent obtained by combining a taxane antitumor agent with a liposome composition in which gemcitabine or a salt thereof is contained in a liposome.

Abstract: An object of the present invention is to provide a tumor therapeutic agent and a kit which have superior antitumor effects as compared with gemcitabine, a taxane antitumor agent, and a combination therapy thereof which have been put on the market. According to the present invention, there is provided a tumor therapeutic agent obtained by combining a taxane antitumor agent with a liposome composition in which gemcitabine or a salt thereof is contained in a liposome.

Abstract: An object of the present invention is to provide a tumor therapeutic agent and a kit which have superior antitumor effects as compared with gemcitabine, a taxane antitumor agent, and a combination therapy thereof which have been put on the market. According to the present invention, there is provided a tumor therapeutic agent obtained by combining a taxane antitumor agent with a liposome composition in which gemcitabine or a salt thereof is contained in a liposome.

Abstract: An object of the present invention is to provide a liposome composition containing a liposome having an excellent leakage rate of a nucleic acid analog anticancer agent, and a method for producing the same. According to the present invention, there are provided a liposome composition containing a liposome which (1) contains a nucleic acid analog anticancer agent and in which (2) a content ratio of a lysophospholipid contained in a lipid forming the liposome with respect to a total amount of phospholipids other than the lysophospholipid contained in the lipid forming the liposome is 0.01 mol % to 5 mol % and (3) a nucleic acid analog anticancer agent/lipid ratio is 2 mass % to 10 mass %, and a method for producing the same.

Abstract: An object of the present invention is to provide a tumor therapeutic agent and a kit which have superior antitumor effects as compared with gemcitabine, a taxane antitumor agent, and a combination therapy thereof which have been put on the market. According to the present invention, there is provided a tumor therapeutic agent obtained by combining a taxane antitumor agent with a liposome composition in which gemcitabine or a salt thereof is contained in a liposome.

Abstract: A wireless communication system includes a first tag installed on a ground outside a track for a running train, the first tag being driven by wirelessly received power, a second tag installed outside a side face of the train and above the first tag, the side face extending in a running direction, the second tag being driven by wirelessly received power, a wireless communicator which is installed in the train and performs wireless communication with the first tag and the second tag, and an antenna which is installed in the train and has a gain in directions of the first tag and the second tag.

Abstract: An information processing apparatus includes a receiving unit and a determining unit. The receiving unit receives read information that is read by a reading unit from a storage medium a plurality of number of times. The determining unit determines abnormality in a reading process performed by the reading unit, based on a first result acquired by comparing a time interval of reading the read information with a first threshold, or on a second result acquired by comparing the number of times the reading is performed with a second threshold.

Abstract: An object of the present invention is to provide a tumor therapeutic agent and a kit which have superior antitumor effects as compared with gemcitabine, a taxane antitumor agent, and a combination therapy thereof which have been put on the market. According to the present invention, there is provided a tumor therapeutic agent obtained by combining a taxane antitumor agent with a liposome composition in which gemcitabine or a salt thereof is contained in a liposome.

Abstract: An object of the present invention is to provide a liposome composition containing a liposome having an excellent leakage rate of a nucleic acid analog anticancer agent, and a method for producing the same. According to the present invention, there are provided a liposome composition containing a liposome which (1) contains a nucleic acid analog anticancer agent and in which (2) a content ratio of a lysophospholipid contained in a lipid forming the liposome with respect to a total amount of phospholipids other than the lysophospholipid contained in the lipid forming the liposome is 0.01 mol % to 5 mol % and (3) a nucleic acid analog anticancer agent/lipid ratio is 2 mass % to 10 mass %, and a method for producing the same.

Abstract: An information processing apparatus includes a receiving unit and a determining unit. The receiving unit receives read information that is read by a reading unit from a storage medium a plurality of number of times. The determining unit determines abnormality in a reading process performed by the reading unit, based on a first result acquired by comparing a time interval of reading the read information with a first threshold, or on a second result acquired by comparing the number of times the reading is performed with a second threshold.

Abstract: A wireless communication system includes a first tag installed on a ground outside a track for a running train, the first tag being driven by wirelessly received power, a second tag installed outside a side face of the train and above the first tag, the side face extending in a running direction, the second tag being driven by wirelessly received power, a wireless communicator which is installed in the train and performs wireless communication with the first tag and the second tag, and an antenna which is installed in the train and has a gain in directions of the first tag and the second tag.

Abstract: An object of the present invention is to provide a method for producing lipid particles which can hold nucleic acids or the like at a high inclusion rate, and a nucleic acid delivery carrier having the lipid particles. According to the present invention, there is provided a method for producing lipid particles including nucleic acids, the method including the following steps of (1) to (4): (1) a step of heating an oil phase containing a phospholipid, an alcohol, and an ester; (2) a step of mixing an oil phase prepared in step (1) with a water phase containing nucleic acids; (3) a step of cooling the mixed liquid which contains the oil phase and the water phase and has been obtained in step (2), and crystallizing lipid particles; and (4) a step of removing the alcohol and the ester from the mixed liquid Which contains the oil phase and the water phase and has been obtained in step (3).

Abstract: According to one embodiment, an apparatus includes a control unit and a coil unit. The control unit generates a first clock signal, generates a data signal to indicate an operating condition, modulates the first clock signal by the data signal to obtain a modulated signal, generates a clock transmission signal including the modulated signal, and emits the clock transmission signal. The coil unit converts the clock transmission signal into an electric signal, detects the modulated signal from the clock transmission signal, generates a second clock signal synchronous with the first clock signal from the modulated signal, detects an MR signal generated in a subject, digitizes, synchronously with the second clock signal, the MR signal, detects the data signal from the detected modulated signal by using of the second clock signal, controls the operating condition of the coil unit to be the operating condition indicated by the data signal.

Abstract: A dental composition for oral use, containing a phosphorylated saccharide (a), a polyphosphoric acid and/or a salt thereof (b), and a cationic bactericidal agent (c), wherein a ratio of a total amount of the phosphorylated saccharide (a) and the polyphosphoric acid and/or a salt thereof (b) contained to an amount of the cationic bactericidal agent (c) contained, i.e. {(a)+(b)}/(c), is from 0.05 to 20 in a weight ratio.

Abstract: According to one embodiment, a wireless transceiver system includes a transmitter and a receiver. The transmitter includes a first generator, a second generator, a third generator. The second generator generates fixed data item that has bit values corresponding to the clock signal. The third generator performs OFDM modulation for the fixed data item. The receiver includes a first detector, a second detector, a PLL, a controller. The first detector is configured to detect an envelope that indicates amplitude in a time waveform. The controller is configured to control to operate the PLL from a first time point when the head part is detected to a second time point when a first period is elapsed.